TradingView
Eli
Dec 23, 2016 4:54 PM

Long ACAD above $30. Target 31 and 35 in January.  

ACADIA Pharmaceuticals Inc.NASDAQ

Description

ACAD in a money squeeze that appears to release soon to the upside coinciding with resistance break through. Daily MACD turned bullish and major MAs turning up. A good long idea upon confirmation of break out.

Trade active

Breakout occurred and Price is back to the $30 breakout level, testing it as support. If support holds, go long still targeting $35. If support fails, 24 and 20 are downside targets.
More